Form4insider filings, from the source

SEC Form 4 · accession 0000914190-16-000930

NEPHROS INC · NEPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daron Evans
Officer — President and CEO · Director
Period of report
Dec 7, 2016
Accepted (ET)
Dec 9, 2016 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 7, 2016P4,069$0.32A339,428D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$0.46holding————Mar 26, 2024Common Stock75,36175,361D
Stock Option (Right to Buy)F2$0.60holding————Apr 15, 2025Common Stock764,468764,468D
Common Stock Warrants (Right to Buy)F3$0.30holding———Jun 3, 2016Jun 3, 2021Common Stock40,00040,000I
Common Stock Warrants (Right to Buy)$0.30holding———Jun 3, 2016Jun 3, 2021Common Stock10,00010,000I
Common Stock Warrants (Right to Buy)$0.30holding———Jun 3, 2016Jun 3, 2021Common Stock10,00010,000I

Explanation of responses